ArticleAnnals of surgical oncology2025

INSIGHT: A Phase III Trial of Ripretinib Versus Sunitinib in Patients with Advanced GIST with KIT Exon 11 and Exon 17/18 Mutations Who Were Previously Treated with Imatinib.

Carolina Larrain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.